Inventor · disambiguated record
Jonathan C. Lansing
Also filed as: LANSING JONATHAN · LANSING JONATHAN C
19 granted patents·23 pending applications·119 citations·filing 2007–2024
94Inventor score
Files withMOMENTA PHARMACEUTICALS INC36PARSONS IAN CHRISTOPHER3LIU CUIHUA1MOMENTA PHARMACEUTCALS INC1SHRIVER ZACHARY1
Top patents by PatentIndex Score
42 records- 0192US11623964B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Apr 11, 2023·6 cites·7 claims
- 0292US11220531B2Engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2018·Granted Jan 11, 2022·6 cites·5 claims
- 0392US11155640B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Oct 26, 2021·6 cites·2 claims
- 0492US11124573B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2019·Granted Sep 21, 2021·6 cites·40 claims
- 0592US10239944B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Mar 26, 2019·13 cites·24 claims
- 0690US8663999B2Characterization of N-glycan mixtures by nuclear magnetic resonancePARSONS IAN CHRISTOPHER·Filed 2012·Granted Mar 4, 2014·14 cites·64 claims
- 0789US9182467B2Comparative analysis of protein conformations by using 2D NOESY NMR spectraPARSONS IAN CHRISTOPHER·Filed 2008·Granted Nov 10, 2015·16 cites·34 claims
- 0889US8216851B2Characterization of N-glycan mixtures by nuclear magnetic resonancePARSONS IAN CHRISTOPHER·Filed 2008·Granted Jul 10, 2012·14 cites·54 claims
- 0987US8921116B2Methods of evaluating diethylamide in peptide mixtures for the preparation of glatiramer acetateMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Dec 30, 2014·5 cites·7 claims
- 1085US2024141401A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1185US2024167069A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1284US7968082B1Evaluating mixtures of low molecular weight heparins by NMRMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Jun 28, 2011·24 cites·21 claims
- 1384US2025011432A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1484US2024279703A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1582US8470603B2Methods of evaluating diethylamide in glatiramer acetateSHRIVER ZACHARY·Filed 2007·Granted Jun 25, 2013·6 cites·13 claims
- 1681US2024067757A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1779US2024209040A1ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1878US8324348B1Evaluation of copolymer diethylamideLIU CUIHUA·Filed 2012·Granted Dec 4, 2012·2 cites·10 claims
- 1975US11827682B2Engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2021·Granted Nov 28, 2023·0 cites·9 claims
- 2074US12297291B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2021·Granted May 13, 2025·0 cites·3 claims
- 2174US12071482B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2021·Granted Aug 27, 2024·0 cites·13 claims
- 2273US2021040527A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2373US2021277438A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2472US2021017563A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2571US8927292B2Methods of evaluating peptide mixturesMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Jan 6, 2015·1 cites·6 claims
- 2670US2020032312A1Sialylated glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2765US8759484B2Evaluation of copolymer diethylamideMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Jun 24, 2014·0 cites·23 claims
- 2865US2018305725A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2962US8765911B2Evaluation of copolymer diethylamideMOMENTA PHARMACEUTICALS INC·Filed 2012·Granted Jul 1, 2014·0 cites·13 claims
- 3060US2016108450A1Sialylated glycoproteinsMOMENTA PHARMACEUTCALS INC·Filed 2014·Application pending·0 cites
- 3157US2014127735A1Characterization of n-glycan mixtures by nuclear magnetic resonanceMOMENTA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3249US2021317227A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3348US2022064298A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO CTLA-4MOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3448US2021284717A1Compositions and methods related to engineered fc-antigen binding domain constructsMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3548US2022267460A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3648US2021147549A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO PD-L1MOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3746US2021238310A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3845US2021269546A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO CD38MOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3944US2025346676A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO CCR4MOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4043US2015252108A1Glycoprotein preparationsMOMENTA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4143US2020040084A1Compositions and methods related to engineered fc-antigen binding domain constructsMOMENTA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4240US12391759B2Methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Aug 19, 2025·0 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →